Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
significant arm pain; flu like symptoms; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix with an associated reaction of no adverse event (received first dose on an unknown date). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: significant arm pain) and influenza-like symptoms (Verbatim: flu like symptoms). The outcome of the pain in arm was not reported and the outcome of the influenza-like symptoms was resolved (duration 12 hrs). The reporter considered the pain in arm and influenza-like symptoms to be related to Shingrix. The company considered the pain in arm and influenza-like symptoms to be related to Shingrix. Additional Information: GSK Receipt Date: 23-JAN-2026 The patient had reported significant arm pain after the second dose of Shingrix. The second dose had given her significant arm pain and had caused her to experience flu like symptoms for about 12 hours. The batch number was not provided, and we are unable to contact the reporter.